Key facts
- Notable investors include Anka Ventures, Etohum, ODTU Teknokent, TEB Girisim Evi.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Oruba
- ·The full record, as it builds
Funding rounds
No funding rounds for Oruba are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oruba
Manufacturer of a medical stimulation device intended to conduct a self-operating urine diagnosis. The company develops point-of-care medical devices with Internet of Things (IoT) technologies and product measures urine flow rate over time and the status of the bladder outlet by giving important indicators for lower urinary tract symptoms, enabling patient to have their urine diagnosis in clean and comfortable environments.
- Sector
- Healthcare
- HQ
- Ankara, Turkey
- Founded
- 2011
- Employees
- 41
- Website
- oruba.health/
- Ownership
- Privately Held (backing)
Oruba doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oruba shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oruba in its N-PORT filings yet. We sweep new filings monthly.